Skip to content

A drug propofol for postoperative nausea and vomiting after laparoscopic surgeries

Comparison of different sub hypnotic doses of propofol for prevention of postoperative nausea and vomiting following laparascopic surgeries : a prospective randomised double blinded study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019671
Enrollment
108
Registered
2019-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: sub hynotic doses of propofol: sub hynotic dose of propofol dose-10mg or 20 mg or 30 mg or normal saline 3 ml duration- at the time skin closure frequency- only one dose to pre

Sponsors

drtmonica daisy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: american society of anaesthesiologist (ASA ) GRADE 1 & 2 AGE 18-65 YEARS MALE AND FEMALE PATIENTS BMI LAPAROSCOPIC SURGERIES

Exclusion criteria

Exclusion criteria: PATIENTS REFUSAL TO THE PROCEDURE PRIOR HISTORY OF MOTION SICKNESS/PONV HISTORY OF ALLERGIC REACTION TO PRPOFOL ADMINISTRATION OF ANTIEMETIC BEFORE SURGERY HISTORY OF CARDIAC/NEUROLOGICAL/GASTROINTESTINAL /RENAL AND HEPATIC DISEASES

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE SUB HYPNOTIC DOSES OF PROPOFOL 10 MG, 20 MG,30 MG FOR PREVENTION OF POST OPERATIVE NAUSEA AND VOMITING FOLLOWING LAPAROSCOPIC SURGERIESTimepoint: TO COMPARE THE SUB HYPNOTIC DOSES OF PROPOFOL 10 MG, 20 MG,30 MG FOR PREVENTION OF POST OPERATIVE NAUSEA AND VOMITING FOLLOWING LAPAROSCOPIC SURGERIES in 108 patients in this three years of study

Secondary

MeasureTime frame
HEMODYNAMIC MONITORING INCIDENCE AND SEVERITY OF NAUSEA AND VOMITING SEDATION IN THESE GROUPS ANY ASOOCIATED SIDE EFFECTSTimepoint: 24 HOURS

Countries

India

Contacts

Public ContactPROFDRLAILU MATHEWS

chettinad academy of research and education

lailu.mathews@gmail.com9443535910

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026